Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1990-05-07
1991-08-20
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514169, 514177, 514178, 514912, 514914, A61K 31565, A61K 3157
Patent
active
050414348
ABSTRACT:
A topical drug application for the alleviation of keratoconjunctivitis sicca (dry eye syndrome) is comprised of a solution of sex steroids or their derivatives suspended or dissolved in a vehicle, and the method of preparation and application of the same. In the preferred embodiments, the sex steroid consists essentially of conjugated estrogen in a lipid vehicle or a derivative of estrogen known as 17 beta-Estradiol 3-phosphate disodium dissolved in an aqueous vehicle having a pH of between 6 and 8.
REFERENCES:
patent: 2861920 (1958-11-01), Dale et al.
patent: 3962430 (1976-06-01), O'Neill
patent: 4082881 (1978-04-01), Chen et al.
patent: 4154820 (1979-05-01), Simoons
patent: 4474751 (1984-10-01), Haslam et al.
patent: 4474811 (1984-10-01), Masuda et al.
patent: 4478818 (1984-10-01), Shell et al.
patent: 4581226 (1986-04-01), Dillon
patent: 4617299 (1986-10-01), Knepper
patent: 4642305 (1987-02-01), Johansson et al.
patent: 4774236 (1988-09-01), Cook et al.
patent: 4812448 (1989-03-01), Knepper
patent: 4861763 (1989-08-01), Cook et al.
patent: 4863912 (1989-09-01), Southren et al.
patent: 4866049 (1989-09-01), Maumenee et al.
patent: 4951683 (1990-08-01), Davis
patent: 4954490 (1990-09-01), Cook et al.
Gans et al., Am. J. Opthalm. 109(4): 474-477, Apr. 1990, Estrogen and Progesterone Receptors and Human Conjunctiva.
Kramer et al., Opthalmol. 97(3): 303-307, Mar. 1990, Cyclic Changes in Conjunctival Smears from Menstruating Females.
Lamble et al., Exp. Eye Res. 26: 599-610 (1978) Some Effects of Progestogens, Oestrogens and Androgens on the Ocular Tension of Rabbits and Owl Monkeys.
Holly et al., Surv. Ophthalm. 22(2): 69-87 (1977) Review: Tear Physiology and Dry Eyes.
*Alcon (1980), Bohigian, Gro, "Handbook of External Diseases of the Eye", pp. 74-79, Dry Eye Syndrome: Diagnosis and Therapy, p. 79 (Special Rx), **** found in file of Johansson et al., U.S. Pat. No. 4,642,305.
*Alcon Brochure, Lemp, M. A. et al., "The Diagnosis and Management of the Dry Eye", **** found in file of Johansson et al., U.S. Pat. No. 4,642,305.
Johansson et al., U.S. Pat. No. 4,642,305, Swedish Priority Document, PTC Int. Search Report.
Vaughan et al., General Opthalmology, 9th Ed. (1980), pp. 54-58, Tears, Dry Eye Syndrome: KCS Keratoconjunctivitis Sicca.
LandOfFree
Drugs for topical application of sex steroids in the treatment o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drugs for topical application of sex steroids in the treatment o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs for topical application of sex steroids in the treatment o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1008059